Earnings call Dr. Lal PathLabs reported FY25 revenue of ₹2,461 crore, up 10.5% YoY, with PAT rising 35.9% to ₹492 crore (including a one-time tax benefit). Q4 margins expanded, but FY26 guidance ...
ET Now on MSN
Dr Lal Path Labs dividend 2026: Rs 4 per share payout in Q4 results FY26 - Record date on June 26
Dr Lal Path Labs Dividend 2026: The BSE 500 company on April 30 announced its Q4 quarterly earnings for financial year ...
April 30 (Reuters) - Dr Lal Path Labs reported a 15.5% drop in fourth-quarter profit on Thursday, hurt by higher tax expenses. Here are some details: • Consolidated net profit fell to 1.31 billion ...
Dr. Lal Path Labs posts earnings dip on Indian labour code changes; test demand strong Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to ...
(Reuters) -Dr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid ...
Bengaluru: Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to India's new labour code, despite strong demand for its bundled test packages.
Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...
Discover Dr Lal Path Labs diagnostic services in New Delhi, Delhi. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...
When my father, Dr SK Lal, decided to make India his country at the time of Partition, and came to Delhi from Rawalpindi, he had 31 dependents with him," recalls (Hony) Brigadier Dr Arvind Lal, ...
Discover Dr Lal Path Labs diagnostic services in Gurgaon, Haryana. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...
Earnings call Dr. Lal PathLabs reported 10.7% YoY revenue growth and 19.3% PAT growth in Q3 FY25, despite no price increases. The company is executing a multi-pronged strategy of geographic expansion, ...
The company's consolidated net profit rose to 967 million rupees ($11.2 million) in the three months to Dec. 31, from 813 million rupees a year earlier, but fell short of analysts' estimate of 976.9 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results